Synthesis and Evaluation of Melphalan-Containing N,N-Dialkylenkephalin Analogues as Irreversible Antagonists of the δ Opioid Receptor

Philip S. Portoghese, Jane A. Lovett

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

N,N-Dialkylated leucine enkephalin analogues containing melphalan (Mel) in place of Phe4were synthesized as potentially irreversible antagonists of the δ opioid receptor. These compounds, along with the corresponding Phe4peptides, were tested for both agonist and antagonist activity in the GPI and MVD smooth muscle preparations. All but two of the eight compounds showed antagonist activity at 1 against [d-a la2,D-Leu5] enkephalin (DADLE) in the MVD when tested under reversible conditions; in all cases the Mel4peptide had lower activity against DADLE than did the corresponding Phe4peptide. At higher concentrations (10 μM) the two active Mel4analogues, (benzyl)2Tyr-Gly-Gly-Mel-Leu (2a) and (allyl)2Tyr-Aib-Aib-Mel-Leu (3a), both showed weak irreversible antagonism at the δ receptor. Compound 2a was a selective irreversible δ opioid antagonist while 3a was an irreversible antagonist at both the μ and δ opioid receptors.

Original languageEnglish (US)
Pages (from-to)1668-1674
Number of pages7
JournalJournal of medicinal chemistry
Volume30
Issue number9
DOIs
StatePublished - Sep 1 1987

Fingerprint Dive into the research topics of 'Synthesis and Evaluation of Melphalan-Containing N,N-Dialkylenkephalin Analogues as Irreversible Antagonists of the δ Opioid Receptor'. Together they form a unique fingerprint.

Cite this